Chemify pricing
No pricing page and no rate card exists, though the site carries a partnering section, a Ways We Work section describing engagement models, and a Genesis product page that names the unit the business is sold in: reserved physical capacity at the synthesis facility, taken by a founding cohort of partners.
How Chemify pricing works
- Pricing model
- Quotation and grant. Disclosed income is philanthropic grant funding for named disease programs, alongside collaboration work with a biotech partner. The company markets molecular design and synthesis to pharmaceutical, biotechnology and materials partners through a partnering inquiry rather than a published commercial structure, and no unit of charge, subscription or software license is offered.
- Implementation
- Not published, and the capital cost sits with the vendor rather than the customer. Chemify built and paid for the Maryhill facility at a stated $16 million and intends to replicate it, so the fixed cost of the synthesis capability is carried on its own balance sheet and funded by equity. Nothing states whether a partner contributes to facility cost, reserves capacity, or pays only for work performed.
The disclosed figures are money actually received rather than deal ceilings: $1.6 million in follow on grant funding from the Gates Foundation announced December 2025, against $3.2 million cumulative across both phases of the tuberculosis and malaria work. One caution: a trade report renders the same cumulative total in sterling where the company's own release states dollars, so two figures circulate for one grant.
Beyond the grants there is nothing: no pharmaceutical contract, no license, no synthesis rate and no capacity price, despite a facility operating since June 2025 and a unit of charge the Genesis page describes without pricing.
Chemify pricing against its alternatives
Published prices for Chemify and the products closest to it. Each figure is as the vendor publishes it, in its own currency and billing unit.
- CChemifyNo published price
- PPostEraNo published price
- DDeep GenomicsNo published price
- SSuperluminal MedicinesNo published price
- TTerray TherapeuticsNot applicable
- EEnvedaNot applicable
- VVariational AICustom project pricing
- AAqemiaNo published price
- BBigHat BiosciencesNo published price
Chemify pricing, answered
How much does Chemify cost?
Chemify does not publish a price. The disclosed figures are money actually received rather than deal ceilings: $1.6 million in follow on grant funding from the Gates Foundation announced December 2025, against $3.2 million cumulative across both phases of the tuberculosis and malaria work.
Does Chemify charge an implementation fee?
Not published, and the capital cost sits with the vendor rather than the customer. Chemify built and paid for the Maryhill facility at a stated $16 million and intends to replicate it, so the fixed cost of the synthesis capability is carried on its own balance sheet and funded by equity. Nothing states whether a partner contributes to facility cost, reserves capacity, or pays only for work performed.